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The incidence of carcinoma following an enterocystoplasty increases with time and is a major concern after such procedures. The aim
of this study was to investigate genetic instability (in the form of numerical chromosomal aberrations) at the enterovesical
anastomosis in patients who had undergone a clam ileocystoplasty using fluorescent in-situ hybridisation (FISH). Fluorescent in-situ
hybridisation was performed on touch preparation samples prepared from fresh endoscopic biopsies obtained from the enterovesical
anastomosis and native bladder remnant (control specimens) of 15 patients who had undergone a clam ileocystoplasty. Fluorescent
in-situ hybridisation was also performed on one squamous cell cancer specimen. Significant aneusomic changes were found at the
enterovesical anastomosis in all 15 patients. Alterations in chromosome 18 copy number were the most frequent abnormal finding
(trisomy 18, n¼8; monosomy 18, n¼7). Nine patients were monosomic for chromosome 9. Isolated monosomy 8 and trisomy 8
were each found in one patient. The control specimens were all normal. An unusually high incidence of polysomic cells was found in
the clam tumour specimen, reflecting the aggressive nature of this cancer. Chromosomal numerical abnormalities occur at the
enterovesical anastomosis following a clam ileocystoplasty and chromosome 18 appears to be a particularly good marker of genetic
instability. The results of this study indicate that morphologically normal tissue obtained from the enterovesical anastomosis displays
evidence of chromosomal instability that may predispose to tumour formation. However, further prospective, blinded, longitudinal
studies are required to establish whether predetermined FISH signal patterns in enterocystoplasty cells in urine or obtained by biopsy
predict the presence or absence of tumour.
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The incidence of carcinoma following an enterocystoplasty
increases with time and there is an urgent need to develop
techniques to identify patients who are at risk of developing a life-
threatening tumour (Ali-El-Dein et al, 2002). Fluorescence in-situ
hybridisation (FISH) of exfoliated bladder cells has been shown to
have a greater sensitivity than conventional urine cytology in the
detection of transitional cell carcinoma of the bladder (Halling
et al, 2000). Possibly therefore, detection of early chromosomal
changes indicative of genomic instability at the enterovesical
anastomosis in patients who have undergone enterocystoplasty
may identify those at high risk of tumorigenesis before a
potentially fatal cancer has occurred.
Preliminary studies using comparative genomic hybridisation
(CGH) identified amplifications on chromosomes 9, 18 and 21 in
deoxyribonucleic acid (DNA) extracted from biopsies obtained
from the enterovesical anastomosis of patients who had undergone
a clam ileocystoplasty. These chromosomal abnormalities were
also present in DNA obtained from the tumours arising in
augmentation cystoplasties, but not in any control samples
obtained from the native bladder remnant (Appanna et al, 2000;
Appanna, 2004). Amplifications on chromosome 8 were only
observed in the augmentation tumours investigated. Although
CGH is a useful cytogenetic technique that assesses chromosomal
alterations on a global scale, its sensitivity is limited as it relies on
bulk tissue analysis. Consequently, rare abnormalities, such as
those in a subgroup of cells within premalignant lesions, may be
missed. In contrast, interphase FISH is a single-cell analysis-based
technique, which allows the detection of vary rare alterations and
is therefore more sensitive than CGH. Therefore, the purpose of
the present study was to further investigate abnormalities
involving chromosomes 8, 9 and 18 (an appropriate FISH probe
specific to chromosome 21 alone is not currently commercially
available) in patients who had undergone a clam ileocystoplasty
using FISH to detect early genetic changes at the enterovesical




Touch sample preparations were obtained from 15 patients
undergoing rigid cystoscopy and biopsy of the urothelium at the
enterovesical anastomosis. In seven patients a clam enterocysto-
plasty had been performed for the treatment of a neuropathic
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sbladder and in eight for treatment of an overactive non-
neuropathic bladder (four of whom had a congenitally unstable
bladder). All patients were augmented with ileum. The average age
of the patients at the time of their biopsy was 35.9 years (median 31
years), with a range of 21–62 years. The average time from the
construction of a clam enterocystoplasty to the present study was
12.5 years (median 12 years), with a range of 6–18 years.
Case report A 53-year-old female presented with painless
haematuria. She had spina bifida occulta and had undergone a
clam ileocystoplasty at the age of 45 for the treatment of a
neuropathic bladder. A cystoscopy diagnosed a tumour of the
anterior bladder remnant close to the enterovesical anastomosis.
The patient underwent a laparotomy, where it was found that the
tumour involved the symphysis pubis. A radical cystectomy,
hysterectomy, bilateral oophorectomy and ileal conduit were
performed. Despite radiotherapy, the patient died the following
year. Macroscopic examination demonstrated a 30mm 20mm
ulcerating tumour on the anterior wall of the bladder. The
neoplasm was located in a urothelial area extending to within
10mm of the ileal margin. Light microscopy revealed a moderately
differentiated squamous cell carcinoma invading into the perive-
sical fat. The urothelium adjacent to the tumour displayed
histological features characteristic of carcinoma in situ, these
changes extending as far as, but not crossing the ileovesical
anastomosis. Away from the tumour, the bladder and bowel
epithelium were inflamed, with no dysplasia. Material taken from
the symphysis pubis showed invasive carcinoma in the fibrous
tissue, but no involvement of bone.
Part of the tumour was dissected from the cystectomy sample
immediately following operation. Touch-sample preparations were
prepared from the fresh tumour material and stored at  201C.
Collection of biopsy samples
Approval for this work was obtained from the local hospital ethics
committee and informed consent was obtained from all patients. It
is standard practice in our unit that patients who have undergone a
clam enterocystoplasty are followed up yearly by performing rigid
cystoscopy and biopsy of the urothelium at the enterovesical
anastomosis. In addition to the usual anastomotic biopsy for
histology, where possible a biopsy was taken from the entero-
vesical anastomosis and from the native bladder remnant at least
3cm from the enterovesical anastomosis (control specimen).
Touch-sample preparations
Touch-sample preparations were prepared with fresh biopsy
material. Bladder biopsies were touched repeatedly onto a
microscope slide, taking care not to smear the sample across the
slide. The slides were air-dried for 10min, immersed twice in
methanol/acetic acid 3:1 (Fisher Scientific, Hampshire, UK) for
20min each and air dried for 30min. Successful touch-sample
preparations were stored at  201C.
Touch-sample pretreatment
Tissue touch preparations were digested with pepsin (300mg
pepsin, 100ml 0.01 M HCl, pH 2.8) at 371C for 7min. The digestion
was arrested by immersing slides in phosphate-buffered saline
(PBS) solution for 5min at room temperature, PBS containing
50mM magnesium chloride at room temperature for a further 5min
and air dried.
Fluorescence in-situ hybridisation
Predigested touch-sample preparations were dehydrated in an
ethanol series and air-dried. Orange, green and aqua fluorescent
centromeric probes (Vysis, Surrey, UK) were used to identify
chromosomes 8, 9 and 18, respectively. All three probes in
hybridisation buffer were simultaneously placed on the target area
of each slide, co-denatured on a hot plate at 751C for 2min and
hybridised in a humidified chamber at 371C for 16h. The slides
were subsequently immersed in 0.4 SSC/0.3% Nonidet-40 (NP-
40) at 731C for 2min, 2 SSC/0.1% NP-40 at room temperature for
30s and air-dried. The samples were counterstained with 10ml
40,60-diamidino-2-phenylindole hydrochloride (DAPI; Vysis, Sur-
rey, UK) and evaluated under an Olympus BX50 microscope
equipped with single and multiple band-pass filters to visualise
orange, green and aqua fluorescent probes. Images were captured
using Macprobe v4.3 (PowerGene) image analysis software. In all,
200 non-overlapping nuclei with clearly visible boundaries were
scored for each sample.
Statistical significance
Normal values were obtained by analysing the data obtained from
the control specimens. The cutoff criteria used in defining results
as normal vs aberrant were defined as 3s.d.’s from the mean of the
control values for each of the chromosomes studied. Consequently,
significant monosomy was considered to be present when it
occurred in 46% of the cells and significant trisomy when it
occurred in 44% of cells. Regression analysis was performed
using Microsoft Excel software.
RESULTS
Fluorescent in-situ hybridisation was successfully performed on
test samples prepared from all 15 patients (Table 1) and 12 of the
15 control specimens (Table 2). No chromosomal abnormalities
were observed in any of the control samples. However, significant
aneusomic changes were found at the enterovesical anastomosis of
all 15 patients despite there being no dysplastic or malignant
changes, observations which suggest that chromosomal abnorm-
alities are present in patients with normal histology.
Alterations in chromosome 18 copy number were the most
frequent abnormal finding and were almost evenly divided
between monosomy (53%; Figure 1A) and trisomy (47%;
Figure 1B). Two patients had both a gain and loss of chromosome
18. Nine patients (60%) were monosomic for chromosome 9, but
no cases of trisomy 9 were found. Only two patients had
chromosome 8 copy number abnormalities; monosomy 8 and
trisomy 8 were each found in one patient. In both these patients,
cells with monosomy and trisomy of chromosome 8 abnormalities
in copy number of chromosome 18 were also present, suggestive of
several chromosomal aberrations. Aneusomy involving at least two
chromosomes was observed in nine patients.
Regression analysis indicated that neither the total number of
aneusomic cells (r
2¼0.008) nor the extent of aneusomy of
chromosome 8 (r
2¼0.149), chromosome 9 (r
2¼0.131) or
chromosome 18 (r
2¼0.189) was influenced by the latent period
between patients undergoing a clam ileocystoplasty and the
collection of biopsies. Furthermore, the age of the patient did
not affect the number of aneusomic cells detected (r
2¼0.127).
Fluorescent in-situ hybridisation performed on touch prepara-
tions obtained from a clam tumour specimen indicated that these
tumours are highly chromosomally unstable. Trisomy of chromo-
somes 8 and 9 as well as both monosomy and trisomy of
chromosome 18 were observed (Table 3), with only 38% of cells
containing two signals for all the three chromosomes studied. The
most striking genetic feature of the tumour material was the high
level (23%) of polysomy (Figure 1C). Furthermore, although the
majority of polysomic cells were either trisomic or tetrasomic,
some showed as many as 16 signals for a given probe (Figure 1C).
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Enterocystoplasty is associated with a low but distinct risk of
malignancy (Greenwell et al, 2001; Ali-El-Dein et al, 2002) and
cancers arising within enterocystoplasties are aggressive and
associated with an extremely poor prognosis (Filmer and Spencer,
1990). Studies using CGH identified chromosomal abnormalities
suggestive of genetic instability at the enterovesical anastomosis of
patients with an enterocystoplasty, which were not present in the
native bladder remnant (Appanna et al, 2000; Appanna, 2004). The
results of the present study are in accord with these observations
(Appanna et al, 2000; Appanna, 2004) and clearly indicate that
genetic changes are present at the enterovesical anastomosis of
patients who have undergone a clam ileocystoplasty prior to the
development of any histological change. In particular, aneusomy of
chromosome 18 was present in 87% (13 out of 15) of patients,
indicating that there may be genes on this chromosome that confer
a particular selective growth advantage within the anastomosis
microenvironment. It is not possible from the results of the present
study to determine whether the chromosomal changes observed
with FISH are essential to the development of tumorigenesis in a
clam enterocystoplasty. However, genomic instability is believed to
be essential for tumorigenesis, rendering the cancer cell genome
more susceptible than normal cells to the development of the
various abnormalities characteristic of neoplasia (Marx, 2002).
In the present study, there was no correlation between the
number of aneusomic changes and the time between a patient
undergoing operation and subsequent biopsy, partly because the
cohort studied was not large enough and partly because the time
between operation and biopsy (range 6–18 years) was not great
enough to detect such associations. It is also possible that local
factors are different for each patient and that the process of
tumorigenesis occurs at a different rate in individual patients, a
suggestion supported by the very wide range (2–40 years) of
reported latency between operation and presentation of tumour
(Lane and Shah, 2000; Sato et al, 2000). Future studies need to be
directed at defining the temporal relations between operation
and the development of chromosomal alterations at the entero-
vesical anastomosis in patients who have undergone entero-
cystoplasty.
Table 2 Number of chromosomes per cell for 200 cells scored from specimens taken from the native bladder remnant (control biopsies)
Chromosome 8 Chromosome 9 Chromosome 18
Patient no. p12X3 p12X3 p12X3
1 7 192 1 6 194 0 7 193 0
2 7 193 0 7 193 0 4 196 0
3 8 191 1 6 194 0 7 192 1
4 5 194 1 7 193 0 5 193 2
5 5 194 1 5 195 0 7 193 0
6 Signal to noise ratio poor due to excess background debris on slide
7 Unsuccessful hybridisation
8 4 196 0 6 194 0 5 194 1
9 3 197 0 5 195 0 4 193 3
10 3 196 1 6 194 0 3 195 2
11 7 193 0 5 194 1 8 191 1
12 4 196 0 6 193 1 3 195 2
13 Too few cells on touch sample preparations
14 4 196 0 9 189 2 4 195 1
15 3 197 0 4 196 0 1 197 2
Table 1 Number of chromosomes per cell for 200 cells scored from specimens taken from the enterovesical anastomosis
Chromosome 8 Chromosome 9 Chromosome 18
Patient no. Age (years)
Time between operation
and biopsy (years) p12X3 p12X3 p12X3
1 28 12 10 189 0 7 193 0 12
a 188 0
2 39 10 6 194 0 24
a 175 1 3 197 0
3 21 6 7 192 1 53
a 147 0 18
a 181 1
4 62 16 6 194 0 32
a 167 1 37
a 162 1
5 23 11 8 191 1 6 194 0 30
a 169 1
6 61 12 6 194 0 7 193 0 41
a 158 1
7 29 11 6 193 1 7 193 0 24
a 174 2
83 4 1 5 2 3
a 177 0 4 196 0 21
a 171 8
a
9 31 13 7 192 1 17
a 181 2 4 168 28
a
10 25 14 5 195 0 15
a 184 1 6 189 5
a
11 48 17 5 194 1 28
a 171 1 3 164 32
a
12 29 13 10 188 1 35
a 177 2 8 188 4
a
13 38 18 8 185 7
a 5 194 1 29
a 177 4
a
14 43 11 3 197 0 44
a 155 2 7 190 3
15 27 9 3 197 0 21
a 177 2 2 176 22
a
aDenotes abnormal findings.
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sCancers forming within enterocystoplasties are extremely
aggressive, with a high attendant mortality (Filmer and Spencer,
1990). In 1990 a review identified 14 cases of carcinoma formation
within an enterocystoplasty (Filmer and Spencer, 1990), and since
that time the number of reported cases has more than trebled. This
paper provides the 48th description of a malignant tumour within
an augmentation cystoplasty reported in the literature. In this
study, the patient presented between-yearly screening with an
advanced tumour and died despite radical surgery. Moreover, five
of the six patients who have presented with a clam tumour at our
own unit have died. All of the tumours presented incidentally and
none were detected by screening, suggesting that currently
accepted yearly cystoscopic surveillance is inadequate and
emphasising the urgent need to develop suitable methods for
identifying those patients at risk of tumour formation early in the
process of tumorigenesis.
The most striking cytogenetic finding in the clam tumour was
the large number of polysomic cells. Polysomy is known to be an
unfavourable prognostic marker and is associated with rapid
progression of a cancer (Gschwendtner and Mairinger, 1999;
Krause et al, 2003; Deliveliotis et al, 2005). Therefore, the presence
of polysomy within this fatal squamous cell carcinoma was
consistent with the aggressive nature of this tumour. Further
studies are required to establish whether such complex chromo-
somal abnormalities are a typical feature of clam cancers.
Generally, where polysomic cells are reported as a feature of
human cancer, they typically have three or four times the haploid
number of chromosomes present. Very occasionally, cells with
higher multiples of the haploid chromosome number have been
reported and are associated with a poor prognosis (Borgstro ¨m
et al, 1976). In the present study, the majority of the tumour
polysomic cells were either trisomic or tetrasomic. However, about
10% of the polysomic cells displayed gross abnormalities and
showed as many as 16 signals for a given probe, suggesting that, in
the squamous cell carcinoma reported here, there was a severe
disturbance that was reflected in the clinical outcome. The findings
are therefore in accord with a previous study, which indicated that
hypertetraploidy was the most important risk factor for tumour
progression and clinical outcome of patients with superficial
bladder cancer (Tachibana et al, 1999).
It seems unlikely that every patient with an enterocystoplasty is
at a high risk of developing a life-threatening tumour as the clam
tumours described in the literature have presented with a highly
variable latency. Therefore, the finding of generalised chromo-
somal changes appears to be a nonspecific marker of cytogenetic
Table 3 Fluorescence in-situ hybridisation on a squamous cell carcinoma
from a clam ileocystoplasty
Number of cells per 200
























Figure 1 (A) Several nuclei from the enterovesical anastomosis
demonstrating chromosome 18 monosomy. (B) Examples of chromosome
18 trisomy in cells originating from a histologically normal entero-
vesical anastomosis. (C) A highly polysomic cell deposited from a
clam tumour (orange – chromosome 8; green – chromosome 9;
aqua – chromosome 18).
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sinstability and may not be helpful in identifying those patients at a
high risk of cancer formation. In the present study, aneusomy of
chromosome 18 appeared to be a good marker for genomic
instability at the enterovesical anastomosis, but concomitant
aneusomy of chromosomes 8 or 9 may be a more discerning
marker to identify those patients who will develop a cancer.
Polysomy was not identified in any of the surveillance biopsies
taken from the enterovesical anastomosis, but was the most
prevalent finding in the squamous cell clam tumour analysed using
FISH. If polysomy is demonstrated at the enterovesical anasto-
mosis following a clam enterocystoplasty in any patients in future,
they should be carefully followed up.
CONCLUSIONS
In conclusion, since cancers occurring within clam ileocystoplas-
ties are highly aggressive and have developed rapidly by the
time they are diagnosed, a method that predicts tumour
formation would be of obvious benefit in the management of
these patients. The results of the present study indicate that
chromosomal losses and gains suggestive of genetic instability
are present in morphologically normal tissue obtained from
patients with an enterocystoplasty. However, further prospective,
longitudinal, blinded studies are required to establish whether
or not predetermined abnormal FISH signal patterns predict
the presence or absence of tumour. Several chromosomal changes
were observed in this study. In particular, chromosome 18
aneusomy was prevalent and may be a useful marker of genetic
instability. Identification of polysomic cells at the enterovesical
anastomosis of patients who have undergone an enterocysto-
plasty would be a cause for concern. However, longitudinal
follow-up of patients is required to confirm whether a particular
type of cytogenetic abnormality is associated with tumour
formation.
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